Aim Care for people with schizophrenia is shifting the locus from long‐stay mental hospitals
to nonspecialized community‐based settings. Knowledge on the care is not a sole property …

Objective Although a relationship between schizophrenia (SCZ), antipsychotic (AP)
medication, and metabolic dysregulation is now well established, the effect of adiposity is …

Objective: Schizophrenia is associated with increased risk of cardiovascular disease (CVD),
although there is variation in risk among individuals. There are indications of shared genetic …

Abstract Background and Hypothesis Individuals at clinical high risk for psychosis (CHR-p)
are less fit than nonclinical peers and show hippocampal abnormalities that relate to clinical …

Objective People with schizophrenia exhibit a high obesity rate. However, little is known
about the prevalence of obesity and its relationship with clinical symptoms and metabolic …

We aimed to perform a systematic review and meta-analysis of appetite regulating
hormones in patients with first-episode psychosis (FEP). Meta-analyses were conducted …

Introduction People with psychosis spectrum disorders (PSD) face an elevated risk of
metabolic syndrome (MetS), which may reduce their life expectancy by nearly 20 …

Although metabolic disorders are common in schizophrenia, few studies investigated sex
differences in metabolic disorder. This study aimed to examine the sex differences in the …

Abstract Background Metabolic syndromes (MetS) are clinical syndromes involving multiple
pathological states with distinct gender-specific clinical patterns. As a serious disorder …

Background In Japan, challenges were reported in accurately estimating the prevalence of
schizophrenia among the general population. Retrieving previous studies, we investigated …